February 2025
1. CHEN JG, Kensler TW, Zhu J, Zhu YR, et al
   Profound primary prevention of liver cancer following a natural experiment in China: A 50-year perspective and public health implications.
   Int J Cancer. 2025;156:756-763.
   

   >> Share

   
   October 2024
2. LIU J, Zhang X, Lin J, Dai C, et al
   HBcrAg is associated with prognosis of hepatitis B virus-related hepatocellular carcinoma in patients after hepatectomy undergoing antiviral therapy.
   Int J Cancer. 2024 Oct 25. doi: 10.1002/ijc.35224.
   

   >> Share

   
   April 2024
3. KARTSONAKI C, Yao P, Butt J, Jeske R, et al
   Infectious pathogens and risk of esophageal, gastric and duodenal cancers and ulcers in China: A case-cohort study.
   Int J Cancer. 2024;154:1423-1432.
   

   >> Share

   
   January 2024
4. ZHAO G, Shi X, Zhang L, Liang H, et al
   Comment on "Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients".
   Int J Cancer. 2024 Jan 11. doi: 10.1002/ijc.34796.
   

   >> Share

   
   
5. KIM MN, Zhang X, Ahn SH
   Reply to: Comments on "Diabetic MAFLD is associated with increased risk of hepatocellular carcinoma and mortality in chronic viral hepatitis patients".
   Int J Cancer. 2024 Jan 11. doi: 10.1002/ijc.34797.
   

   >> Share

   
   August 2023
6. HA Y, Lim J, Chon YE, Kim MN, et al
   Five-year on-treatment variables-based PPACS model predicts subsequent hepatocellular carcinoma in entecavir/tenofovir-treated patients.
   Int J Cancer. 2023 Aug 24. doi: 10.1002/ijc.34704.
   

   >> Share

   
   

Free Medical Abstracts
Privacy Policy
Sponsors
Share